# The senescent cells we thought were harmful are repairing injured tendons > For years, cellular senescence carried the label of a mechanism of decline, tied to tissue aging and chronic diseases such as osteoarthritis - Author: Maxime Marquette - Publisher: MadMax (https://mad-max.co) - Section: Profile - Published: 2026-07-06 - Canonical URL: https://mad-max.co/en/article/ces-cellules-senescentes-qu-on-croyait-nuisibles-reparent-nos-tendons-blesses ## Key takeaways - The study, led by Professor Shen Liu of Shanghai Sixth People's Hospital, was published June 11, 2026, in the journal Bone Research (the article also says the research was reported in early July 2026). - The researchers identified cells expressing p16INK4a, a marker of cellular senescence, which appear temporarily at the injury site. - In animal models, early elimination of these cells led to less effective tendon repair. - The cells appear to secrete signaling molecules that recruit other repair cells and coordinate early healing. - The author notes a growing distinction between harmful chronic senescence and transient, useful acute senescence, and warns against untargeted use of senolytics during tendon repair. ## Introduction: the unexpected turnaround of a maligned cell ### A **reputation** in need of a full rewrite For years, **cellular senescence** carried the label of a mechanism of **decline**, tied to **tissue aging** and chronic diseases such as **osteoarthritis** or certain **cancers**. A new study published in early July 2026 upends this uniformly negative picture by revealing that some **senescent cells** play an active, beneficial role in repairing injured tendons. This unexpected finding, documented by a team of Chinese **researchers**, offers a major shift in perspective on cells long viewed as mere biological waste to be cleared away rather than potential therapeutic allies. ### Why this discovery speaks to anyone who has ever suffered from tendinitis **Tendon injuries** affect millions of people every year, from occasional **athletes** to manual **workers**, to older adults suffering **degenerative tears**. The central problem with these injuries remains imperfect healing: tendons often scar with **fibrous tissue** that is less elastic than the original tissue, which durably raises the risk of new injuries. It is precisely this challenge that the new research tries to illuminate, by identifying an unexpected cellular player in the repair process. *There is something reassuring about discovering that a cell we associated exclusively with biological decline can, in a specific context, play a repairing role. Biology clearly refuses categories that are too simple.* ## What this study actually reveals about tendon repair ### A Chinese team at the heart of the discovery The study, led by Professor **Shen Liu** of **Shanghai Sixth People's Hospital**, was published on **June 11, 2026** in the scientific journal **Bone Research**. The researchers identified a **specific population** of cells expressing the **marker** **p16INK4a**, a **classic indicator** of cellular senescence, which appears transiently at the **site of a tendon injury**. Contrary to the **dominant hypothesis** that these cells should be eliminated to support optimal healing, the researchers observed that they actively helped orchestrate certain **key stages** of **tissue repair**. ### An experiment that changes the picture By genetically manipulating the presence of these **p16INK4a-positive cells** in **animal models**, the research team was able to observe the **direct consequences** of their absence or their **early elimination**. The results showed less effective tendon repair when these cells were removed too early in the healing process. This observation directly contradicts **therapeutic strategies** that, until recently, aimed to systematically eliminate senescent cells to prevent the **harmful effects** associated with tissue aging. *This kind of result reminds me that in biology, the intent to do good, eliminating a cell judged harmful, can sometimes produce the opposite of what was intended.* ## Understanding cellular senescence beyond the clichés ### A biological mechanism more complex than assumed **Cellular senescence** refers to a state in which a cell stops dividing while remaining metabolically active. This mechanism is traditionally tied to **aging**, the buildup of tissue damage, and **chronic inflammation**, a phenomenon sometimes called **inflammaging** in the **scientific literature**. But this new study belongs to a more recent research trend that distinguishes **chronic senescence**, which is harmful, from transient, acute senescence, which can instead serve useful physiological functions, particularly in **wound healing** and tissue regeneration. ### An essential signaling function According to the researchers, the senescent cells identified at the site of the tendon injury appear to secrete **signaling molecules** that recruit other **repair cells** and orchestrate the earliest stages of healing. This **biological coordination** function explains why their early removal harms the quality of the repair observed. This distinction between useful and harmful senescence could redefine the way **biomedical research** approaches cellular aging as a whole. *This nuance between **acute** and chronic senescence strikes me as one of the most important contributions of this study, well beyond the single case of tendons.* ## The still-cautious therapeutic implications of this discovery ### Rethinking anti-senescence strategies For several years, a booming **research field** has been developing molecules called **senolytics**, designed to selectively eliminate senescent cells in the body, in hopes of slowing certain aging processes or treating chronic diseases. This new study calls for greater caution in applying these treatments, at least in the specific context of healing acute injuries. The authors suggest that **untargeted use** of **senolytics** during the tendon repair phase could, paradoxically, harm the quality of healing rather than improve it. ### No promise of a miracle treatment at this stage It is important to stress that this research remains at a preclinical stage, conducted mainly on animal models. No treatment for human **patients** suffering from tendon injuries has been validated based on these results. The researchers themselves call for **further studies** before considering any clinical application. This methodological caution must be scrupulously respected, especially for an audience suffering from chronic tendon pain and legitimately searching for concrete solutions. *I refuse to turn this discovery into a premature therapeutic promise. Hope must stay measured, even when the science is exciting.* ## Why tendons normally heal so poorly ### A tissue with a distinctive structure **Tendons** have a **dense fibrous structure**, mainly composed of **type I collagen**, organized to withstand significant **mechanical forces**. This specialized structure, essential to their function, nonetheless makes them particularly hard to regenerate after an injury, unlike other, better-vascularized tissues. Tendon healing generally results in the formation of disorganized fibrous tissue, less resistant and less elastic than the original tendon, which explains the **high rate** of **recurrence** observed in patients who have suffered a tendon tear. ### An underestimated public health problem Tendon injuries represent a considerable economic and human **burden**, affecting elite **athletes** as much as workers exposed to **repetitive motions**. Understanding the fine biological mechanisms of tendon repair could eventually pave the way for treatments capable of improving the **quality of scar tissue**, not just its quantity. It is in this context that the discovery of the beneficial role of senescent cells takes on its full potential clinical meaning. *We often underestimate the real toll tendon injuries take on people's daily lives. This research deserves to be followed closely for exactly that reason.* ## What this discovery reveals about the complexity of living systems ### A lesson in humility for biomedical research This study illustrates a broader trend in contemporary biology: the questioning of overly simple **binary categories** that systematically pit mechanisms judged purely beneficial against others judged purely harmful. Biological reality is almost always more nuanced, dependent on context, timing, and the tissue involved. This complexity requires researchers to exercise constant methodological caution before generalizing a conclusion drawn from a specific **experimental context** to an entire biological phenomenon. ### Toward more context-sensitive research on cellular aging Rather than seeking to systematically eliminate every trace of cellular senescence in the body, part of the **scientific community** is now advocating for a **more refined approach**, capable of distinguishing contexts where this senescence is useful from those where it becomes harmful. This conceptual shift could have **repercussions** well beyond the sole field of tendon repair, potentially reaching research on **aging in general**. *It is this ability to add nuance to an established theory, rather than reject it outright, that separates good science from dogmatic science.* ## The next steps expected by the scientific community ### Further research needed The study's authors explicitly call for additional work to determine whether these results observed in animal models hold true in humans. More extensive **preclinical trials** will also need to establish precisely at which point in healing these **beneficial senescent cells** play their role, and from what point their **persistence** instead becomes problematic. This precise **time window**, if confirmed, could guide the development of future treatments capable of preserving these cells during the **acute phase** of repair, while eliminating them once their function is complete. ### A field of research in full ferment **Cellular senescence** remains one of the most dynamic fields in the **biology of aging**, with potential implications for numerous **chronic conditions**, ranging from osteoarthritis to **cardiovascular disease**. This study on tendons illustrates the need to approach this research field with great **precision**, tissue by tissue, context by context. Future publications on this topic will be followed with **close attention** by a scientific community increasingly aware of the complexity of these cellular mechanisms. *I am curious to see the next steps of this research, while keeping in mind that it will likely take years before any concrete clinical application emerges.* ## What this could mean for patients in the coming years ### Measured hope for injured athletes and workers For people living with **recurring tendon injuries**, this research does not bring an immediate solution, but it charts a clear direction for the years ahead. If future trials confirm the beneficial role of these **transient senescent cells** in humans, this could one day influence how clinicians manage the acute phase of healing, particularly by avoiding certain overly aggressive **anti-inflammatory treatments** at the wrong moment. This caution matters all the more because many patients, searching for **quick fixes**, sometimes turn to unvalidated experimental therapies. This study is a reminder of the importance of following established **medical guidance** rather than unproven promises. ### Research that will first benefit **basic science** In the short term, the main beneficiaries of this discovery will be researchers themselves, who now have an additional lead for understanding the fine mechanisms of **tissue repair**. Concrete clinical applications, if confirmed, will likely take several years to materialize. This is the **normal pace** of serious biomedical research, even if the timeline may feel frustrating to patients hoping for quick solutions to their **chronic pain**. *I would rather announce a **realistic timeline** than let people believe a treatment is imminent. It is a matter of respect toward people who genuinely suffer from these injuries.* ## Conclusion: a discovery that calls for nuance rather than hype ### What this study actually changes This research does not overturn the entire body of knowledge on the harmful effects of chronic cellular senescence, but it considerably enriches our understanding of the role certain senescent cells can play in specific contexts such as acute tendon repair. It is an essential nuance, not a complete revolution of the field. For patients suffering from tendon injuries, no immediate clinical application follows from this study. But it opens a promising research avenue that could eventually improve the quality of **tendon healing** beyond currently available treatments. ### An invitation to scientific patience As is often the case in biomedical research, the path from a laboratory discovery to a treatment available to patients remains long, strewn with uncertainties and necessary **further validations**. This study deserves to be followed with interest, without generating expectations disproportionate to its current stage of development. It is this honesty about the limits of current knowledge that, in my view, gives this discovery its full credibility. *If I had to take one idea away from this story, it would be this: even cells we assume are destined to do harm can, at the right moment, become precious allies of healing.* **By Maxime Marquette, columnist** ## Columnist's transparency note ### Editorial stance I am not a journalist but a **columnist and analyst**. My expertise lies in observing and analysing the geopolitical, economic and strategic dynamics that shape our world. My work is to take political strategies apart, to understand global economic movements, to put the decisions of international actors in context and to offer analytical perspectives on the changes that are redefining our societies. I do not claim the cold objectivity of traditional journalism, which stops at reporting facts. **I claim analytical clarity**, rigorous interpretation and a deep understanding of the complex issues that concern us all. My role is to give meaning to the facts, to place them in their historical and strategic context, and to offer a critical reading of events. ### Method and sources This text keeps the basic distinction between **verified facts and interpretive analysis**. The rule never changes: a factual claim is published only when a verifiable source supports it, and the sources this article actually used are listed under **Sources**, never here. **Primary source families** used by the publication, when the story has them: official statements from governments and international institutions, public statements by political leaders, reports from intergovernmental organisations, dispatches from recognised international news agencies. **Secondary source families**: specialised publications, internationally recognised news media, analyses from established research institutions, reports from industry organisations. When an article cites statistical, economic or geopolitical data, it comes from the institutions that produce it (intergovernmental organisations, central banks, national statistics offices), and the exact institution is named under **Sources**. ### Nature of the analysis The analyses, interpretations and perspectives in the analytical sections of this article are a **critical, contextual synthesis** based on the information available, the trends observed and the expert comments cited in the sources consulted. My role is to interpret these facts, to set them in the context of today's geopolitical and economic dynamics, and to give them a coherent meaning within the larger story of the changes shaping our time. These analyses reflect expertise built through continuous observation of international affairs and an understanding of the strategic mechanisms that drive global actors. This article describes a documented state of affairs on its publication date, not a prediction: later developments may shift its outlook. No update is promised in advance; when an article is corrected or completed, the change is dated in the text. ## Sources ### Primary sources - Scienmag, medical science news — July 2026 - News-Medical, medical science news — July 3, 2026 ### Secondary sources - Medical Xpress, health science news — July 2026 - News-Medical, medical research news — July 2026 - EurekAlert, health and science news — July 2026 - Nature, Tendon research section — July 2026 --- Source: Maxime Marquette, MadMax. When citing, name the author and link https://mad-max.co/en/article/ces-cellules-senescentes-qu-on-croyait-nuisibles-reparent-nos-tendons-blesses